Page 104 - CL Armchair Case
P. 104
Unlike Daraprim, Imprimis's formulation in itself is not FDA
approved, and can only be used when prescribed by a
doctor for a particular patient.
“An undated presentation highlighted Mr. Shkreli’s experience
with other prescription drug price increases, including
Daraprim, Chenodal, and Thiola. The presentation stated:
“increased Chenodal price 5x with no pushback from payors ...
Licensing of Thiola … Increased price 21x with no pushback
from payors … Acquisition of Daraprim … Increased price 43x
with no pushback from payors.” (4)
Turing, in late November, said it would cut the price of
Daraprim by up to 50% for some patients.